InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Prior Stephen David. Director active across 1 company, notably AN2 Therapeutics, Inc.. Cumulatively, 5 reports have been recorded. Split: 0 buy · 3 sells. Total volume traded: €6k. Activity tracked since 4 November 2024. The latest transaction was disclosed on 5 January 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Prior Stephen David is a declarant linked to AN2 Therapeutics, Inc., where he is Chief Strategy Officer. He has 5 filings in total, and across the 5 recent sampled filings between 2024-11-05 and 2026-01-07, the activity consists entirely of sales, with total sales of EUR 6495 and no buys.